Nomura Holdings Inc. Purchases Shares of 22,539 Option Care Health, Inc. (NASDAQ:OPCH)

Nomura Holdings Inc. acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 22,539 shares of the company's stock, valued at approximately $523,000.

Several other large investors also recently added to or reduced their stakes in the stock. Murphy & Mullick Capital Management Corp bought a new stake in shares of Option Care Health in the 4th quarter valued at about $26,000. UMB Bank n.a. raised its holdings in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after purchasing an additional 346 shares in the last quarter. Signaturefd LLC raised its holdings in shares of Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after purchasing an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC raised its holdings in shares of Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after purchasing an additional 1,099 shares in the last quarter. Finally, Johnson Financial Group Inc. bought a new stake in shares of Option Care Health in the 4th quarter valued at about $47,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Stock Up 2.3%

Shares of NASDAQ OPCH traded up $0.71 during trading hours on Tuesday, hitting $32.12. 827,855 shares of the stock were exchanged, compared to its average volume of 1,858,791. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a market cap of $5.26 billion, a PE ratio of 26.99, a PEG ratio of 2.30 and a beta of 0.76. The firm has a fifty day moving average price of $32.89 and a 200-day moving average price of $29.47. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. Option Care Health's revenue was up 16.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.26 EPS. On average, sell-side analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Buying and Selling

In related news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.64% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

OPCH has been the subject of several recent research reports. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. JPMorgan Chase & Co. boosted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. JMP Securities restated a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. Finally, Barrington Research restated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.